Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and Patient Support Program in Patients With Chronic Hepatitis C
N/A
The interferon-free combination regimen of paritaprevir/r - ombitasvir with...
Status
Completed
Location
Albert Schweitzer Ziekenhuis /ID# 152597
Start Date
2016-01-20
Trial ID
NCT02817594
A Study to Evaluate Treatment of Hepatitis C Virus Infection in Pediatric Subjects
PHASE2
This was a Phase 2/3, open-label, multicenter study to evaluate the pharmac...
A Follow up Study Designed to Obtain Long Term Data on Participants Who Either Achieved a Sustained Virologic Response or Did Not Achieve a Sustained Virologic Response in an AbbVie Sponsored Hepatitis C Study
PHASE3
A follow-up study to assess resistance and durability of response to 3 expe...
Ombitasvir/ABT-450/Ritonavir and Dasabuvir Therapy With Low Dose Ribavirin (RBV), Full Dose RBV or RBV Add-On in Treatment Naive Genotype 1a Hepatitis C Virus Infected Adults
PHASE2
To evaluate the effect of ribavirin on second phase plasma hepatitis C viru...
A Study to Evaluate the Safety and Antiviral Effect of ABT-450/Ritonavir and ABT-530 Coadministered With and Without Ribavirin in Adults With Genotype 3 Hepatitis C (HCV) Infection
PHASE2
The purpose of this study is to evaluate the safety and antiviral effect of...
Drug Use-Results Survey in Participants Infected With Hepatitis C Virus Genotype 2
N/A
The main objective of this study is to evaluate the safety and effectivenes...
Status
Completed
Location
Aichi Medical University Hosp /ID# 161892
Start Date
2016-10-26
Trial ID
NCT02945228
A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) in People With Hepatitis C Virus Infection Who Have Not Had Treatment Before
PHASE3
This is a study to evaluate the efficacy and safety of three experimental d...